{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:26:45Z","timestamp":1773055605837,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ymgme.2004.06.020","type":"journal-article","created":{"date-parts":[[2004,8,28]],"date-time":"2004-08-28T06:29:38Z","timestamp":1093674578000},"page":"288-296","source":"Crossref","is-referenced-by-count":18,"title":["Global gene expression in a type 2 Gaucher disease brain"],"prefix":"10.1016","volume":"83","author":[{"given":"Rachel","family":"Myerowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine L.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura S.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Proia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2004.06.020_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of Glucocerebrosides. Evidence of an Enzymatic Deficiency in Gaucher\u2019s Disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2004.06.020_bib2","first-page":"3635","article-title":"Gaucher disease","volume":"vol. III","author":"Beutler","year":"2001"},{"key":"10.1016\/j.ymgme.2004.06.020_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0065-3101(24)00049-5","article-title":"New perspectives in type 2 Gaucher disease","volume":"44","author":"Sidransky","year":"1997","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2004.06.020_bib4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2004.06.020_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197411072911901","article-title":"Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher\u2019s disease","volume":"291","author":"Brady","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2004.06.020_bib6","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1073\/pnas.74.10.4620","article-title":"Enzyme replacement therapy in Gaucher\u2019s disease: preliminary clinical trial of a new enzyme preparation","volume":"74","author":"Beutler","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2004.06.020_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2004.06.020_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S","article-title":"Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease","volume":"15","author":"Stone","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2004.06.020_bib9","first-page":"3827","article-title":"The GM2 gangliosidoses","volume":"vol. 3","author":"Gravel","year":"2001"},{"key":"10.1016\/j.ymgme.2004.06.020_bib10","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2004.06.020_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"Orvisky","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2004.06.020_bib12","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M300212200","article-title":"Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms","author":"Lloyd-Evans","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2004.06.020_bib13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1096\/fj.02-0149fje","article-title":"Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide","volume":"16","author":"Bodennec","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2004.06.020_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/hmg\/11.11.1343","article-title":"Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling","volume":"11","author":"Myerowitz","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2004.06.020_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.270.5235.484","article-title":"Serial analysis of gene expression","volume":"270","author":"Velculescu","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2004.06.020_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1385-299X(01)00119-2","article-title":"High stability of mRNAs postmortem and protocols for their assessment by RT-PCR","volume":"8","author":"Yasojima","year":"2001","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.ymgme.2004.06.020_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1096-8628(20000320)91:3<222::AID-AJMG13>3.0.CO;2-#","article-title":"Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses","volume":"91","author":"Finn","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2004.06.020_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/bioinformatics\/16.7.650","article-title":"eSAGE: managing and analysing data generated with serial analysis of gene expression (SAGE)","volume":"16","author":"Margulies","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymgme.2004.06.020_bib19","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1101\/gr.192601","article-title":"A comparative molecular analysis of developing mouse forelimbs and hindlimbs using serial analysis of gene expression (SAGE)","volume":"11","author":"Margulies","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.ymgme.2004.06.020_bib20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.295.5559.1457a","article-title":"American Association for the Advancement of Science annual meeting. Human gene count on the rise","volume":"295","author":"Shouse","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2004.06.020_bib21","first-page":"3371","article-title":"Sphingolipid Activator Protiens","volume":"vol. III","author":"Sandhoff","year":"2001"},{"key":"10.1016\/j.ymgme.2004.06.020_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2001-3-1-reviews3002","article-title":"The synucleins","volume":"3","author":"George","year":"2001","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymgme.2004.06.020_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","article-title":"The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease","volume":"21","author":"Clayton","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ymgme.2004.06.020_bib24","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2004.06.020_bib25","doi-asserted-by":"crossref","first-page":"34328","DOI":"10.1074\/jbc.M004345200","article-title":"alpha-Synuclein membrane interactions and lipid specificity","volume":"275","author":"Jo","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2004.06.020_bib26","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer Disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2004.06.020_bib27","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2004.06.020_bib28","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2004.06.020_bib29","first-page":"742","article-title":"Stimulation of breast cancer invasion and metastasis by synuclein gamma","volume":"59","author":"Jia","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymgme.2004.06.020_bib30","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","article-title":"Axon pathology in Parkinson\u2019s disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein","volume":"96","author":"Galvin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2004.06.020_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2004.06.020_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.0.CO;2-B","article-title":"Parkinson\u2019s syndrome preceding clinical manifestation of Gaucher\u2019s disease","volume":"61","author":"Machaczka","year":"1999","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2004.06.020_bib33","doi-asserted-by":"crossref","unstructured":"N. Tayebi, J. Walker, B. Stubblefield, E. Orvisky, M.E. LaMarca, K. Wong, H. Rosenbaum, R. Schiffmann, B. Bembi, E. Sidransky, Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Molecular Genetics and Metabolism 80 (2003), on line","DOI":"10.1016\/S1096-7192(03)00071-4"},{"key":"10.1016\/j.ymgme.2004.06.020_bib34","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood.V96.7.2584","article-title":"Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE","volume":"96","author":"Suzuki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2004.06.020_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1097-4547(19980101)51:1<49::AID-JNR5>3.3.CO;2-2","article-title":"Murine microglial cells express functionally active galectin-3 in vitro","volume":"51","author":"Pesheva","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2004.06.020_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V94.3.837.413k02_837_844","article-title":"Serial analysis of gene expression in human monocytes and macrophages","volume":"94","author":"Hashimoto","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2004.06.020_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3940(96)13040-8","article-title":"Complement gene expression in mouse microglia and astrocytes in culture: comparisons with mouse peritoneal macrophages","volume":"216","author":"Haga","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2004.06.020_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1098-1136(200007)31:1<39::AID-GLIA40>3.0.CO;2-1","article-title":"Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse","volume":"31","author":"Van Beek","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2004.06.020_bib39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00001756-200105080-00022","article-title":"Inflammatory stimuli increase prostaglandin D synthase levels in cerebrospinal fluid of rats","volume":"12","author":"Ishizaka","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.ymgme.2004.06.020_bib40","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1062960","article-title":"The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease","volume":"294","author":"Chabas","year":"2001","journal-title":"Science"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671920400160X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671920400160X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T08:06:48Z","timestamp":1705219608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671920400160X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S109671920400160X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2004.06.020","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}